The potential roles of the blood–brain barrier and inflammation in PKAN and MPAN patients were examined using the following biomarkers: MMP-9, ICAM-1, E- and P-selectin, and S100B. Here, MMP9 is linked to pantothenate kinase-associated neurodegeneration.